Jazz Pharmaceuticals plcJAZZNASDAQ
LOADING
|||
Cash Generation Expanding
Trending higher, above historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$1.35B
↑ 87% above average
Average (9y)
$718.86M
Historical baseline
Range
High:$1.35B
Low:$408.95M
CAGR
+11.7%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $1.35B | +26.2% |
| 2023 | $1.07B | +38.0% |
| 2022 | $773.78M | +5.6% |
| 2021 | $732.98M | +40.9% |
| 2020 | $520.39M | -12.4% |
| 2019 | $594.07M | -11.0% |
| 2018 | $667.43M | +15.2% |
| 2017 | $579.14M | +41.6% |
| 2016 | $408.95M | -17.5% |
| 2015 | $495.99M | - |